Skip to main content
OpenTrials
Completed

NCT Number: NCT03873220

Monitoring Of Scratch Via Accelerometry In Children

Sleep sensors, wrist worn accelerometers, polysomnography (PSG), and associated data analysis platforms would provide quantitative and qualitative knowledge regarding the action of scratching and sleep quantity in a symptomatic atopic dermatitis (AD) population. The overall aim of this research is to validate the use of sensor technology and digital measures to quantitatively and qualitatively evaluate scratch and sleep in AD patients, and specifically in this study in children ages 2 to 11 years. To evaluate this experimental paradigm, the investigators propose using wearable accelerometers, a sleep sensor, PSG, videography and associated traditional patient-reported outcome measures/clinical outcome assessments (PRO/COA) in patients/caregivers with AD in a well-controlled in-laboratory and at-home study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atopic Dermatitis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

2 year–11 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Evans Biomedical Research Center

Boston, Massachusetts, 02118, United States

About this study

To assess the feasibility of quantifying scratch and sleep in children with Atopic Dermatitis (AD), children, age 2 to 11 years, with AD will be recruited. The subjects will complete specific questionnaires related to itch, sleeping habits and AD and continuously wear two wrist worn accelerometry devices. The EarlySense Sleep Monitor will also be placed underneath the mattress to measure additional sleep related activities.

The study will be comprised of two overnight sleep laboratory site visits. The clinic visits will be followed by a continuous ~48 hour in-home environment assessment period (defined as the subject's daily routine environment). During the sleep lab site visit, the subject and accompanying parent(s)/guardian(s) will sleep overnight at the facility. The subject will be video-recorded during the in-sleep lab visit, wear the wrist accelerometry devices, use the sleep sensor and complete assessments (Depending on age, parent/guardian may complete some assessments). Upon the completion of sleep lab activities the subjects will then continue to wear the wrist accelerometry devices, utilize the sleep sensor and complete Patient Reported Outcome/Clinical Outcome Assessments (PRO/COA) assessments during the 48 hour in-home assessment. At the conclusion of the in-home portion of the assessment, the subject will return the device/s and assessments to the facility and undergo brief assessments/interview.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female subjects aged ≥2 years of age and <12 years of age at Day 1.
  • Written informed consent from parent(s)/guardian(s) and assent from the subject (where assent is applicable).
  • Native English speakers or demonstrated fluency in English (both subject and parent(s)/guardian(s)).
  • Has a clinical diagnosis of Atopic Dermatitis (AD) according to the criteria of Hanifin and Rajka (concomitant AD treatments are permitted on study).

Exclusion criteria

  • AD affected surface areas are in a location of device placement.
  • Has unstable AD (Total BSA>40%).
  • Has any planned surgical or medical procedure that would overlap with study participation.

Treatment and study plan

Wrist Actigraphy Devices

Device

A watch-like wearable sensor

Other names: GENEActiv Watch

Sleep Monitor

Device

Remote Sensor

Other names: EarlySense

Polysomnography

Device

Sleep Monitor

Videography

Device

Thermal Camera

Primary outcomes

  1. Quantification of scratch using GENEActiv watches to assess triaxial accelerometry

    Time frame: From enrollment through the end of visit 5 (5 days +/- 2 days).

    One GENEActiv watch will be used on each hand at a sampling rate of 100 Hz to measure movement in the x, y, and z direction. The movement will be analyzed using the algorithm described by Cole et al. to differentiate between periods of wakefulness and sleep.

  2. Quantification of sleep using Polysomnography

    Time frame: From enrollment through the end of visit 5 (5 days +/- 2 days).

    Polysomnography (PSG) will be used to report the number of sleep occurrences and appropriate sleep staging based on the scoring guide provided by the American Academy of Sleep Medicine (AASM) for children. The following sleep stages will be scored: Stage W (wakefulness), Stage N1 (NREM 1), Stage N2 (NREM 2), Stage N3 (NREM 3), Stage N (NREM), and Stage R (REM).

Sponsors and collaborators

Lead sponsor

Boston University

Other

Registry information

Official study title

Feasibility for Quantification of Scratch Behavior and Sleep in Children With Atopic Dermatitis

Acronym: MOSAIC

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Mar 13, 2019
Registry last updated
Dec 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.